Applied DNA Sciences Receives a Buy from Maxim Group


In a report released today, Anthony Vendetti from Maxim Group maintained a Buy rating on Applied DNA Sciences (NASDAQ: APDN), with a price target of $5. The company’s shares closed yesterday at $1.49.

Vendetti said:

“F2Q18 (Mar) revenue of $1.0M, up 15.3%, was slightly above our estimate of $0.9M. GAAP EPS of ($0.07) compared to ($0.13) in F2Q17, was narrower than our estimate of ($0.12). On May 3, 2018, APDN announced a multi-year licensing agreement with WestPoint Home, a textiles manufacturing company, to supply its CertainT platform services for WestPoint’s hospitality bedding and textile goods. After the completion of a research project with the BLC Leather Technology Centre on May 1, 2018, APDN confirmed that DNA marking throughout the leather supply chain is feasible by employing its SigNature molecular tags.”

Vendetti has an average return of 2.1% when recommending Applied DNA Sciences.

According to TipRanks.com, Vendetti is ranked #451 out of 4773 analysts.

Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $5.

See today’s analyst top recommended stocks >>

The company has a one-year high of $3.45 and a one-year low of $0.90. Currently, Applied DNA Sciences has an average volume of 55.17K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Applied DNA Sciences, Inc. engages in the security solutions. It provides biotechnology-driven solutions to help protect products, brands, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts